Providers

Providers

AIT Bioscience Joins Science Exchange to Offer Online Access to Bioanalytical Solutions

AIT Bioscience’s CEO, Terri Pascarelli, expressed her excitement about the partnership with Science Exchange saying, “We are proud to team up with Science Exchange to offer end-to-end bioanalytical services to pharmaceutical and biotech organizations. We are the first and only CRO in the world to provide solutions for all molecule types (large, small, and peptides/biomarkers) in a purpose-built facility utilizing a fully electronic analytical lab notebook system. We continue to invest in our people, processes and equipment to meet our clients’ growing demands. Our bioanalytical services range from discovery through commercialization to support screening, IND-enabling tox programs, and clinical development. We’re ready to meet you where you are for research and development needs.”
AIT Bioscience logo
Terri Pascarelli
CEO

Science Exchange, the world’s leading marketplace for R&D services, announced a collaboration with AIT Bioscience, LLC, an emerging contract research organization (CRO), to offer online access to its bioanalytical services. AIT Bioscience’s services include ligand-binding assays across many platforms, mass spectrometry-based analyses, and cell-based assays. 

AIT Bioscience‘s capabilities help increase accuracy and efficiency of bioanalytical data delivery, especially in regulated environments. Through this collaboration, AIT Bioscience’s services can be rapidly accessed by Science Exchange’s clients at leading R&D organizations worldwide.

About AIT Bioscience

AIT Bioscience, LLC, headquartered in Indianapolis, Indiana, is an integrated contract research laboratory that provides continuous process monitoring and real-time quality control processes in Ligand Binding Assay (LBA) analytics for large molecules and LC-MS/MS analytics for small molecules in pre-clinical and phase I – III clinical trials. The integration of these services, supported by a state-of-the-art smart electronic laboratory environment, allows AIT Bioscience to formulate the best solution for its clients, across all bioanalytical methods. AIT Bioscience delivers robust analytical methods, highly knowledgeable client consultation, efficient sample logistics and rapid sample analysis from pre-IND through investigational new drug (IND) and new drug application (NDA). 

ABOUT THE AUTHOR
author

Max Smith-Gee

Operations Manager, Science Exchange

Max Smith-Gee, MBA (Organizational Management, Kingston University London) is an Operations Manager at Science Exchange with +5 years experience in the Pharmaceutical and Biotechnology sectors with 3 of those years in Account Management. Max's goal is to enrich our Provider network and to further accelerate scientific research.

Leave a Reply

Your email address will not be published.